• News
  • BioTech

Cadence reports strong sales for acetaminophen injection

San Diego-based Cadence Pharmaceuticals Inc. (Nasdaq: CADX) has announced a preliminary estimate of net product revenue from sales of its Ofirmev acetaminophen injection for the three months ended Dec. 31, 2012.

To continue reading, subscribe now
log in to your account
User Response
0 UserComments

Cadence Pharmaceuticals Inc.

Company Website

12481 High Bluff Dr. Ste., 200
San Diego, CA 92130

Cadence Pharmaceuticals Inc. Executive(s):

Theodore Schroeder

  • Chief Executive Officer, President

Similar Companies

Subscribe Today!